Colgate Palmolive (CL) Capital Expenditures (2009 - 2026)

Colgate Palmolive's Capital Expenditures history runs 18 years deep, the most recent figure standing at $138.0 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 11.29% year-over-year to $138.0 million; the TTM figure through Mar 2026 stood at $578.0 million (up 3.4% YoY), while the FY2025 annual figure was $564.0 million, up 0.53% from the prior year.
• Capital Expenditures was $138.0 million for Q1 2026 at Colgate Palmolive, down from $177.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $221.0 million in Q4 2022 to a low of $108.0 million in Q2 2025.
• Historically, Capital Expenditures has averaged $156.7 million across 5 years, with a median of $161.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures jumped 36.92% in 2022, then tumbled 36.41% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $221.0 million in 2022, then dropped by 10.86% to $197.0 million in 2023, then decreased by 6.6% to $184.0 million in 2024, then dropped by 3.8% to $177.0 million in 2025, then fell by 22.03% to $138.0 million in 2026.
• The last three Capital Expenditures figures came in at $138.0 million (Q1 2026), $177.0 million (Q4 2025), and $155.0 million (Q3 2025), per Business Quant data.